Filana Therapeutics, Inc. SEC filings FLNA
Filana Therapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Nov 9, 2006. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Other events
|
Oct 20, 2026 | Oct 20, 2026 |
| 4 | Insider transaction | Oct 1, 2026 | Sep 29, 2026 |
| 4 | Insider transaction | Sep 30, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 22, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Listing notice
|
Sep 18, 2026 | Sep 17, 2026 |
| 10-Q | Quarterly report | Jul 29, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 15, 2026 | Jun 11, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| ARS | Annual report to shareholders | Apr 28, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 28, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 28, 2026 | Apr 22, 2026 |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 19, 2026 | Feb 19, 2026 |
| 8-K |
Current report
Material agreement
|
Dec 23, 2025 | Dec 19, 2025 |
| 8-K/A |
Amended current report
Officer or director change
|
Dec 22, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Other events
|
Dec 18, 2025 | Dec 15, 2025 |
| 8-K |
Current report
Officer or director change
|
Dec 17, 2025 | Dec 12, 2025 |
| EFFECT | Filing | Dec 5, 2025 | — |
| 424B2 | Prospectus | Dec 5, 2025 | — |
| CORRESP | Letter to the SEC | Dec 3, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 3, 2025 | Nov 26, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Nov 24, 2025 |
| 4 | Insider transaction | Nov 24, 2025 | Nov 20, 2025 |
| 4 | Insider transaction | Nov 20, 2025 | Nov 19, 2025 |
| S-3 | Shelf registration | Nov 13, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Other events
|
Oct 24, 2025 | Oct 23, 2025 |
| 4 | Insider transaction | Oct 22, 2025 | Oct 21, 2025 |
| 3 | Initial insider ownership | Oct 22, 2025 | Oct 21, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 22, 2025 | Oct 21, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 30, 2025 |
| 4 | Insider transaction | Sep 23, 2025 | Sep 22, 2025 |
| 4 | Insider transaction | Sep 22, 2025 | Sep 18, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2025 | Sep 8, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 4, 2025 | Aug 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 16, 2025 | — |
| 4 | Insider transaction | Jul 16, 2025 | May 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 30, 2025 | Jun 30, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 27, 2025 | May 23, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
May 27, 2025 | May 23, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 4 | Insider transaction | Apr 21, 2025 | Apr 17, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 21, 2025 | Apr 15, 2025 |
| ARS | Annual report to shareholders | Apr 14, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 14, 2025 | May 23, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 3, 2025 | May 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 25, 2025 | Mar 25, 2025 |
| 8-K |
Current report
Officer or director change
|
Mar 11, 2025 | Mar 6, 2025 |
| 10-K | Annual report | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Results of operations, Exit or restructuring costs, Other events
|
Jan 7, 2025 | Jan 7, 2025 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| 4 | Insider transaction | Dec 3, 2024 | Nov 29, 2024 |
| 144 | Notice of proposed sale | Dec 2, 2024 | — |
| 144 | Notice of proposed sale | Nov 29, 2024 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 26, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 25, 2024 | Nov 25, 2024 |
| 4 | Insider transaction | Nov 20, 2024 | Nov 18, 2024 |
| 3 | Initial insider ownership | Nov 20, 2024 | Nov 18, 2024 |
| 4 | Insider transaction | Nov 20, 2024 | Nov 18, 2024 |
| 3 | Initial insider ownership | Nov 20, 2024 | Nov 18, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 8, 2024 | Oct 8, 2024 |
| 4 | Insider transaction | Oct 1, 2024 | Oct 1, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Oct 1, 2024 | Sep 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 27, 2024 | Sep 26, 2024 |
| 8-K |
Current report
Other events
|
Sep 17, 2024 | Sep 13, 2024 |
| 4 | Insider transaction | Sep 9, 2024 | Sep 6, 2024 |
| 4 | Insider transaction | Sep 9, 2024 | Sep 6, 2024 |
| 4 | Insider transaction | Sep 9, 2024 | Sep 6, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 9, 2024 | Sep 6, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 21, 2024 | — |
| 8-K/A |
Amended current report
Results of operations
|
Aug 9, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations, Listing notice
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 22, 2024 | Jul 22, 2024 |
| 8-K |
Current report
Other events
|
Jul 18, 2024 | Jul 18, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure, Other events
|
Jul 17, 2024 | Jul 15, 2024 |
| 8-K |
Current report
Other events
|
Jul 1, 2024 | Jul 1, 2024 |
| 8-K |
Current report
Officer or director change
|
May 22, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 22, 2024 | May 20, 2024 |
| 4 | Insider transaction | May 16, 2024 | May 16, 2024 |
| 8-K |
Current report
Shareholder vote results
|
May 13, 2024 | May 9, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 9, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 9, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 9, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 9, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 9, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 9, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 9, 2024 |
| 4 | Insider transaction | May 13, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 10, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 10, 2024 | May 10, 2024 |
| 8-K |
Current report
Other events
|
May 8, 2024 | May 8, 2024 |
| 25-NSE | Delisting notice | May 3, 2024 | — |
| 8-K |
Current report
Other events
|
May 1, 2024 | May 1, 2024 |
| 4 | Insider transaction | Apr 30, 2024 | Apr 26, 2024 |
| 4 | Insider transaction | Apr 25, 2024 | Apr 23, 2024 |
| 4 | Insider transaction | Apr 22, 2024 | Apr 18, 2024 |
| 4 | Insider transaction | Apr 17, 2024 | Apr 17, 2024 |
| 8-K |
Current report
Other events
|
Apr 15, 2024 | Apr 15, 2024 |
| DEF 14A | Proxy statement | Mar 26, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Mar 22, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Feb 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 13, 2024 | — |
| 8-K |
Current report
Other events
|
Feb 7, 2024 | Feb 7, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 1, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 26, 2024 | — |
| CERT | Filing | Jan 3, 2024 | — |
| 424B2 | Prospectus | Jan 3, 2024 | — |
| 8-A12B | Filing | Jan 3, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jan 3, 2024 | Jan 3, 2024 |
| 8-A12G | Filing | Jan 2, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 12, 2023 | Dec 12, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Dec 11, 2023 | Dec 6, 2023 |
| 4 | Insider transaction | Dec 8, 2023 | Dec 6, 2023 |
| 3 | Initial insider ownership | Dec 8, 2023 | Dec 6, 2023 |
| 4 | Insider transaction | Dec 7, 2023 | Dec 6, 2023 |
| 4 | Insider transaction | Dec 7, 2023 | Dec 6, 2023 |
| 3 | Initial insider ownership | Dec 7, 2023 | Dec 6, 2023 |
| 3 | Initial insider ownership | Dec 7, 2023 | Dec 6, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 4 | Insider transaction | Oct 4, 2023 | Oct 3, 2023 |
| 4 | Insider transaction | Oct 4, 2023 | Oct 3, 2023 |
| 4 | Insider transaction | Oct 4, 2023 | Oct 3, 2023 |
| 4 | Insider transaction | Oct 4, 2023 | Oct 3, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 13, 2023 | Sep 8, 2023 |
| 4 | Insider transaction | Aug 24, 2023 | Aug 23, 2023 |
| 4 | Insider transaction | Aug 23, 2023 | Aug 21, 2023 |
| UPLOAD | Letter from the SEC | Aug 14, 2023 | — |
| CORRESP | Letter to the SEC | Aug 10, 2023 | — |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| UPLOAD | Letter from the SEC | Jul 28, 2023 | — |
| 8-K |
Current report
Other events
|
Jul 5, 2023 | Jul 5, 2023 |
| 4 | Insider transaction | Jun 12, 2023 | Jun 12, 2023 |
| 4 | Insider transaction | May 25, 2023 | May 24, 2023 |
| 4 | Insider transaction | May 10, 2023 | May 10, 2023 |
| 4 | Insider transaction | May 8, 2023 | May 4, 2023 |
| 4 | Insider transaction | May 8, 2023 | May 4, 2023 |
| 4 | Insider transaction | May 8, 2023 | May 4, 2023 |
| 4 | Insider transaction | May 8, 2023 | May 4, 2023 |
| 4 | Insider transaction | May 8, 2023 | May 4, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 8, 2023 | May 4, 2023 |
| 4 | Insider transaction | May 2, 2023 | May 1, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended
|
May 1, 2023 | Apr 26, 2023 |
| 424B5 | Prospectus supplement | May 1, 2023 | — |
| S-3ASR | Automatic shelf registration | May 1, 2023 | — |
| 10-Q | Quarterly report | May 1, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 1, 2023 | May 1, 2023 |
| DEF 14A | Proxy statement | Mar 27, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Mar 17, 2023 | Mar 16, 2023 |
| ARS | Annual report to shareholders | Mar 16, 2023 | Dec 31, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 16, 2023 | — |
| 8-K |
Current report
Other events
|
Mar 10, 2023 | Mar 10, 2023 |
| 4 | Insider transaction | Mar 8, 2023 | Mar 7, 2023 |
| 4 | Insider transaction | Mar 8, 2023 | Mar 6, 2023 |
| 10-K | Annual report | Feb 28, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 8, 2023 | — |
| 5 | Annual insider ownership | Feb 7, 2023 | Dec 31, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 1, 2023 | — |
| 8-K |
Current report
Other events
|
Jan 24, 2023 | Jan 24, 2023 |
| 5 | Annual insider ownership | Jan 3, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 22, 2022 | Dec 19, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 22, 2022 | Nov 18, 2022 |
| 424B5 | Prospectus supplement | Nov 21, 2022 | — |
| 10-Q | Quarterly report | Nov 7, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2022 | Nov 3, 2022 |
| 4 | Insider transaction | Oct 31, 2022 | Oct 28, 2022 |
| 3 | Initial insider ownership | Oct 31, 2022 | Oct 28, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 27, 2022 | Oct 13, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FLNA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1069530
- Former names
- CASSAVA SCIENCES INC (until Feb 19, 2026); PAIN THERAPEUTICS INC (until Mar 25, 2019)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.